AMN Healthcare Services, Inc. (NYSE: AMN) Overview and Analyst Insights

• Jeffrey Silber from BMO Capital sets a price target of $22 for AMN Healthcare (NYSE:AMN), indicating a potential increase of about 31.66%.
• AMN Healthcare reports adjusted EPS of 30 cents, surpassing the Zacks Consensus Estimate by 76.5%, despite a year-over-year decline.
• The company's revenues were $658.2 million, a decrease of 11.1% year over year but still above the Zacks Consensus Estimate.

On August 11, 2025, Jeffrey Silber from BMO Capital set a price target of $22 for AMN Healthcare (NYSE:AMN). At the time, AMN's stock was priced at $16.71, suggesting a potential increase of about 31.66% to reach the target. AMN Healthcare is a leading provider of healthcare staffing and workforce solutions in the United States, competing with companies like Cross Country Healthcare and CHG Healthcare.

AMN Healthcare recently reported its second-quarter 2025 results, which exceeded expectations. The company achieved adjusted earnings per share (EPS) of 30 cents, surpassing the Zacks Consensus Estimate by 76.5%. However, this EPS represents a 69.4% decline from the previous year. Despite the decline, the earnings beat indicates some positive aspects in the company's financial performance.

The company's revenues for the quarter were $658.2 million, marking an 11.1% decrease year over year. Nevertheless, this figure still surpassed the Zacks Consensus Estimate by 0.9%. This revenue performance suggests that AMN Healthcare is managing to maintain a steady flow of income despite the challenges it faces in the current market environment.

AMN Healthcare is experiencing challenges with its margins. The gross margin fell to 29.8%, and the operating margin decreased to 6.4% in the second quarter. Additionally, the company reported a GAAP loss per share of $3.02, compared to an EPS of 42 cents in the same period last year. These margin pressures are a concern for investors, as highlighted by the nearly 7.3% drop in AMN's shares in pre-market trading.

Currently, AMN's stock price is $16.50, reflecting a decrease of 4.29% with a change of $0.74. The stock has fluctuated between a low of $16.45 and a high of $17.59 during the day. Over the past year, AMN has reached a high of $59.19 and a low of $14.87. The company's market capitalization is approximately $631.7 million, with a trading volume of 574,738 shares on the NYSE.

• AMN Healthcare Services, Inc. (NYSE:AMN) reported a quarterly revenue of $658 million and an adjusted EBITDA of $58.3 million.
• BMO Capital maintained an "Outperform" rating for AMN, adjusting its price target from $27 to $22.
• Despite a GAAP loss of $3.02 per share, AMN's adjusted earnings per share was $0.30, indicating underlying profitability.

AMN Healthcare Services, Inc. (NYSE:AMN) is a leading player in the healthcare staffing industry, offering a wide range of workforce solutions and staffing services to healthcare facilities across the United States. The company competes with other healthcare staffing firms like Cross Country Healthcare and CHG Healthcare, providing services such as travel nurse staffing, locum tenens staffing, and allied staffing.

On August 11, 2025, BMO Capital maintained its "Outperform" rating for AMN, while keeping the action as "hold." At that time, AMN's stock price was $16.73. BMO Capital also adjusted its price target for AMN, lowering it from $27 to $22. This adjustment reflects a more cautious outlook on the stock's potential growth.

AMN reported its financial results for the second quarter of 2025, with a quarterly revenue of $658 million and an adjusted EBITDA of $58.3 million. Despite these strong figures, the company faced a GAAP loss of $3.02 per share due to noncash goodwill and intangible asset impairment charges totaling $128 million, or $2.81 per share. However, the adjusted earnings per share was $0.30, indicating underlying profitability.

The revenue for the quarter was near the high end of AMN's guidance, and the adjusted EBITDA margin exceeded expectations. Notably, AMN's allied staffing business surpassed its revenue projections, while other segments performed in line with expectations. This performance highlights the company's ability to meet and exceed its financial targets in certain areas.

Currently, AMN's stock price is $16.87, reflecting a decrease of 2.15% or $0.37. During the day, the stock fluctuated between a low of $16.54 and a high of $17.59. Over the past year, AMN has experienced a high of $59.19 and a low of $14.87. The company's market capitalization is approximately $645.9 million, with a trading volume of 174,961 shares on the NYSE.

• The consensus price target for AMN Healthcare Services, Inc. (NYSE: AMN) has significantly declined, but Jefferies maintains a positive outlook with a much higher price target.
• Early indicators suggest a potential revenue beat for Q1 2025, supported by less-than-expected decline in contract labor spending by HCA Healthcare.
• Innovative solutions like WorkWise and ShiftWise Flex are expected to drive significant revenue growth, leveraging changes in U.S. demographics and healthcare coverage.

AMN Healthcare Services, Inc. (NYSE: AMN) is a leading provider of healthcare workforce solutions and staffing services in the U.S. The company operates through three main segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. These segments offer services like travel nurse staffing, locum tenens staffing, telehealth, and workforce optimization.

The consensus price target for AMN's stock has seen a significant decline over the past year, dropping from $49.8 to $25. This change reflects a shift in analysts' expectations, possibly due to market conditions or company performance. However, Jefferies has set a much higher price target of $175, indicating a positive outlook for AMN's future.

Despite the drop in the consensus price target, early indicators suggest AMN Healthcare may report a revenue beat for Q1 2025. This potential revenue growth is supported by HCA Healthcare's contract labor spending, which decreased by only 10.5% compared to the anticipated 18% decline. This suggests a possible bottom in the healthcare staffing market.

AMN Healthcare's innovative solutions, such as WorkWise and ShiftWise Flex, are expected to drive significant revenue growth. These solutions enhance operational efficiency and are well-positioned to benefit from changes in U.S. age demographics and an increase in insured individuals. This positions AMN for strong financial performance and supports the higher price target set by Jefferies.

In Q4 2024, AMN Healthcare reported significant sequential revenue growth for the first time in two years, indicating a potential end to its cyclical decline. While acquisitions are paused due to high debt levels, the company's long-term growth drivers, such as platformization and an expanded technology segment, remain strong. This supports the positive outlook and price target set by Jefferies.